In the coming years, the continued growth and aging of our population will both increase the demand for treatment with implantable cardiac rhythm devices and stretch our ability to pay for care. Toward solving this, we must continue to improve clinical quality not just to provide a better future for patients, but to control costs so that we are able to meet the increased demand.
